SCHEMBL29045709

SCHEMBL29045709

CC(OC(=O)NCCO)C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
GRM1 Q13255 1/20 0.35
GAA P10253 1/20 0.35
ACHE P22303 5/20 0.34
RAB9A P51151 1/20 0.34
CTSK P43235 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
PTGS1 P23219 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20354392 1.00 CHRNB2 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL19508896 0.85 CHRNB2 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4MEN1
SCHEMBL19508892 0.80 ALDH1A1 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL20052073 0.80 CHRNB2 (0.46) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL18591656 0.80 CHRNB2 (0.46) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL606535 0.79 CHRNB2 (0.49) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL20052072 0.79 EPHX1 (0.58) ACHE
SCHEMBL19509262 0.77 ALDH1A1 (0.42) TDP1MEN1KMT2AALDH1A1MAPT
SCHEMBL19509266 0.76 GRM1 (0.32) MEN1KMT2AGRM1GAACTSK
SCHEMBL15149482 0.76 MEN1 (0.45) SMN1; SMN2MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116323601-A 2- (3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl) -acetamide derivatives as transforming growth factor-beta receptor I/ALK5 inhibitors 阿戈麦布西班牙股份有限公司 2023-06-23 CN disclosed